ABSTRACT. In this study, we compared the functional properties of endothelial progenitor cells (EPCs) derived from halfpipe-snowboarding athletes who train under hyperoxic conditions with those derived from normal subjects who lived under normoxic conditions. Peripheral bloodderived EPCs were isolated from both halfpipe-snowboarding athletes and normal humans. Cellular growth dynamics, lipoprotein transport, and gene expression of cultured EPCs were compared between the two groups of cells. Results indicate that cytoactivity of EPCs from athletes was higher than that of EPCs from control subjects. This study suggests that function of EPCs from snowboarding athletes may be better than that of EPCs from normal humans, which demonstrates the benefits of training under hyperoxic conditions.
INTRODUCTION
Endothelial progenitor cells (EPCs) are precursors of vascular endothelial cells (Asahara et al., 1997) . EPCs originate from the bone marrow angioblast and umbilical vein endothelial cells, which together belong to a subgroup of hematopoietic stem cells (Spadaccio et al., 2010) . Two sources of EPCs can be detected in vitro, early and late EPCs. While early EPCs display spindle-shaped, linear growth structures, late EPCs form cobblestone-like, oval shaped structures (Gulati et al., 2003; Bai et al., 2012) . EPCs not only take part in vascularization during embryonic development, but also participate in postnatal vascularization and post-trauma reparative processes (Bonello et al., 2006) . Therefore, EPCs hold extensive prospects for vascular tissue engineering as well as possible clinical applications in coronary artery diseases and wound healing (Gulati et al., 2003) . Snowboarders are a special population of athletes who train under hyperoxic conditions for extended periods of time. The functions of various body systems, especially the respiratory and cardiovascular systems, are more efficient than those of their normal human counterparts who live under normoxic conditions. In this study, the specific functional properties of EPCs from halfpipe-snowboarding athletes were compared with that from normal subjects.
MATERIAL AND METHODS

Blood collection
Peripheral blood was sampled from healthy halfpipe-snowboarding athletes on the Chinese national team. This study was approved by the Harbin Institute of Physical Education Ethics Committees of the Human Movement Sciences Center. Informed written consent was obtained from each athlete prior to blood collection.
Isolation and culture of endothelial progenitor cells
Peripheral blood-derived mononuclear cells were harvested using 1.077 g/mL Percoll solution (Sigma-Aldrich, St. Louis, MO, USA). The Percoll solution was slowly added into a centrifuge tube followed by 5 mL peripheral blood. The tube was centrifuged at 400 g for 20 min. The white nebulous layer was collected and washed twice with DMEM, and centrifuged at 200 g for 5 min. A cell suspension containing the majority of the EPCs was obtained using anti-CD34 antibody via flow cytometry. Cells were seeded on fibronectin-coated plastic plates in EGM-2MV medium, and cultured at 37°C in 5% CO 2 . Half of the media was replaced after 3 days, and media was then fully replaced once every 3 days. When cultured cells reached 70 to 80% confluence, they were passaged with 0.25% (w/v) trypsin and subcultured at 1:3 ratio.
Growth dynamics of endothelial progenitor cells
To assess changes in growth dynamics, EPCs from athletes and normal humans were seeded onn 24-well plates at a density of 1.0 x 10 4 cells/well, and cultured for 8 days. Cells were counted every day thereafter for up to 8 days. The mean cell counts determined in triplicate wells at each time point was used to plot growth curves. The population doubling time was also calculated using the following formula:
where t0 is the starting culture time, t is the time of culture termination, N0 is the initial cell numbers of the culture, and Nt is the total cell number at the end of culture period.
Comparison of lipoprotein transport in endothelial progenitor cells from athletes and normal humans
EPCs derived from athletes and normal humans were washed three times for 5 min each in PBS, and then incubated in media containing 12 mg/mL acetylated Dil low density lipoprotein for 4 h at 37°C and 5% CO 2 . Cells were then washed three more times, fixed with 2% paraformaldehyde, and incubated for 1 h with FITC-Oxytropis lectin 1 (10 mg/mL) at room temperature. Cells were observed and analyzed using the Nikon TE-2000-E confocal microscope system.
Real-time PCR
The relative expression of EPC molecular markers in EPCs from athletes and normal humans was compared using real-time PCR. Total RNA was extracted from EPCs using Trizol (Invitrogen, USA). Isolated RNA was reverse transcribed and used as a template for 30 PCR cycles with the RNA PCR kit version 3.0 (TaKaRa, China). Real-time PCR was performed in 20-µL reaction mixtures containing 10 µL SYBR premix Ex Taq buffer (TaKaRa), 0.4 µL ROX reference dye, 0.8 µM forward and reverse primers (Table 1) , 1 µL cDNA template, and 7 µL ddH 2 O. The cycling parameter was as follows: 10 s at 95°C followed by 40 cycles of two-temperature cycling: 5 s at 95°C and 34 s at 60°C. Each experiment was performed in duplicate on 96-well plates, and was repeated five times. Gene expression was detected on an ABI 7500 real-time PCR system (ABI, USA). The relative expression level of each gene was calculated by the 2 -∆∆Ct method.
RESULTS
Isolation and culture of endothelial progenitor cells
Phase contrast micrographs of EPCs cultures are presented in Figure 1A , which shows the typical cobblestone morphology of late EPCs. No differences were observed between the cellular morphology of EPCs from either athletes or normal humans. EPCs from athletes were passaged 55 times and maintained in culture for 114 days with no sign of senescence
or differentiation. However, EPCs from normal humans were only passaged 45 times and maintained in culture for 102 days before signs of senescence and differentiation were observed ( Figure 1B) . 
Growth dynamics of EPCs
The growth curves demonstrated that EPCs from athletes had higher proliferation potential. After a period of latency (1-4 days), the cells grew in clusters. Cell growth then entered a logarithmic phase, and reached a plateau phase at approximately day 6 when cell numbers reached 6.3 x 10 6 . The growth of EPCs from normal humans also reached the plateau phase at approximately day 6, and reached a total number of 5.21 x 10 6 cells ( Figure 2A) . Similarly, the population doubling time of EPCs from athletes was measured to be 33.12 h while that of normal subjects was 43.32 h. (Figure 2B ).
Comparison of lipoprotein transport in EPCs
EPCs have the ability to take up acetylated Dil low-density lipoprotein and FITCOxytropis lectin 1. Therefore, the capacity of EPCs from athletes and normal subjects to take up these two proteins was tested. The results showed a visible difference in lipoprotein transport between the two sources of EPCs (Figure 3) . 
Comparison of EPC molecular markers
The relative expression of EPC molecular markers including fetal liver kinase (Flk), CD31, Von Willebrand factor (vWF), CD133, and CD34 in EPCs from the two groups was compared using real-time PCR. Results demonstrated that expression level of CD133 was lower in EPCs from athletes as compared with EPCs isolated from normal humans. On the contrary, the expression levels of Flk, CD31, and vWF were higher in EPCs from athletes as compared with those derived from normal humans. The expression level of CD34 was similar across the two groups (Figure 4) . + cells) were first isolated from peripheral blood by Asahara et al. (1997) (Choi et al., 2014) . These cells have the ability to differentiate into mature endothelial cells, and take part in angiogenesis. EPCs and hematopoietic stem cells originate from angioblasts located in the blood islands (Vasa et al., 2001; Shah et al., 2014) . EPCs are usually isolated from umbilical cord blood or peripheral blood. It was proposed that EPCs could be used in cell therapies in diseases involving defects during angiogenesis, such as ischemia. Many experiments performed in different models confirmed that these cells were highly involved in the revascularization of ischemic tissues, and their specific tropism for the diseased tissues was very encouraging (Yamashita et al., 2000; Shintani et al., 2001; Strauer et al., 2002; Zhao et al., 2014) . Low levels of circulating EPCs were thought to be related to increased cardiovascular risks, and could be a byproduct of a number of mechanisms. Various factors such as oxidative stress levels, nitric oxide activities, or other physiologic processes, could directly influence the mobilization or half-lives of EPCs (Hill et al., 2003; Zhang et al., 2006) .
Snowboard athletes train for extended periods under high oxygen conditions, and therefore have developed more efficient circulatory functions, such as oxygen transport and revascularization, as compared with normal humans who live under normoxia. In this study, EPCs were isolated from peripheral blood of snowboarding athletes and normal humans. Results indicated that cell proliferation and lipoprotein transport was enhanced in EPCs from athletes as compared with EPCs from normal humans. It is known that endothelial cell surface heparan sulfate proteoglycans can hydrolyze triglycerides in lipoproteins, especially chylomicrons and very low-density lipoproteins. Lipoprotein is not synthesized by vascular endothelial cells, but is produced by the underlying adipocytes and myocytes. The physiological actions of lipoproteins are mediated primarily by the pool of lipoprotein located at the luminal surface of the endothelium. Therefore, the capacity for lipoprotein transport is an important function for endothelial cells. We found that the capacity for lipoprotein was higher in EPCs from athletes as compared with that in EPCs from normal humans. The results also demonstrated that expression level of CD133, a marker for progenitor cells, was lower in EPCs from normal humans as compared to that from athletes, which suggested that EPCs from athletes have higher tendencies for cell differentiation. CD133 (also known as AC133) is a marker for hematopoietic stem cells and EPCs, and is gradually lost as EPCs differentiate into mature endothelial cells (Peichev et al., 2000; Schmeisser et al., 2001) . vWF also functions as a specific marker for endothelial cell lineage. It is produced by endothelial cells, and is located in the cytoplasm of Weibel-Palade bodies (Feranil et al., 2005; Stamper et al., 2007) . Therefore, vWF and Weibel-Palade bodies serve as specific markers for endothelial cell differentiation. Our results suggested that the EPCs from athletes were more inclined to differentiate into endothelial cells as compared with EPCs from normal humans.
CONCLUSION
In conclusion, we characterized the differences between two source EPCs, and have demonstrated that EPCs from snowboarding athletes had higher cytoactivity and capacity for differentiation as compared with EPCs from normal humans. This finding suggests that conditions of hyperoxia can enhance functions of EPCs.
